Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 311

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Major bleeding during anticoagulation after cerebral ischemia: Patterns and risk factors

Gorter, J.W., for the Stroke Prevention In Reversible Ischemia Trial (SPIRIT), European Atrial Fibrillation Trial (EAFT) Study Groups·1999·Neurology

Abstract

OBJECTIVE: To assess independent predictors of hemorrhage in 651 anticoagulated patients. BACKGROUND: An excess incidence of major bleeding (7% per year) in patients with nondisabling cerebral ischemia of presumed arterial origin treated with oral anticoagulation led to early termination of the Stroke Prevention In Reversible Ischemia Trial (SPIRIT). METHODS: The relationship between known risk factors and hemorrhage was assessed by univariate and multivariate analyses. We compared the risk factors with those in 225 patients anticoagulated because of cerebral ischemia with atrial fibrillation in the European Atrial Fibrillation Trial (EAFT). RESULTS: Leukoaraiosis (hazard ratio [HR] 2.7, 95% confidence interval [CI] 1.4 to 5.3) and age older than 65 years (HR 1.9, 95% CI 1.0 to 3.4) were independent predictors of all anticoagulation-related hemorrhages in SPIRIT. The incidence of intracranial bleeding in SPIRIT was 3.7% per year; this incidence increased by a factor of 1.37 for each 0.5 unit international normalized ratio (INR). Patients with cerebral ischemia of presumed arterial origin had a 19 times (95% CI 2.4 to 150) higher risk of intracranial hemorrhages than those with atrial fibrillation after correcting for baseline differences between SPIRIT and EAFT patients. CONCLUSIONS: In addition to the intensity of anticoagulation, leukoaraiosis and age older than 65 years are independent risk factors for bleeding in patients anticoagulated because of cerebral ischemia of presumed arterial origin. These patients have a higher inherent risk of anticoagulation-related intracranial hemorrhages than patients with atrial fibrillation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.53.6.1319

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 6

  1. The Sixty Plus Reinfarction Study Research Group.A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1980;2:989–994.
  2. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group.Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 1994;353:499–503.
  3. 10.1001/archneur.1991.00530210042021 · doi:10.1001/archneur.1991.00530210042021
  4. Rosendaal FR. The Scylla and Charybdis of oral anticoagulant treatment. Lancet 1996;335:587–598.
  5. 10.1136/jnnp.52.7.829 · doi:10.1136/jnnp.52.7.829
  6. 10.1016/S0002-9343(89)80689-8 · doi:10.1016/s0002-9343(89)80689-8 · Paper page

Cited by

See all 311

Metadata

Authors
Gorter, J. W., (SPIRIT), F. T. S. P. I. R. I. T., & Groups, E. A. F. T. (. S.
Venue
Neurology
Published
1999-10
Volume
53
Issue
6
Pages
1319-1319
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2130047524
Cited by
311
References
22
FWCI
10.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Major bleeding during anticoagulation after cerebral ischemia: Patterns and risk factors. https://app.cochat.ai/papers/10.1212/wnl.53.6.1319
The paper
Gorter, J. W., (SPIRIT), F. T. S. P. I. R. I. T., & Groups, E. A. F. T. (. S. (1999). Major bleeding during anticoagulation after cerebral ischemia: Patterns and risk factors. Neurology. https://doi.org/10.1212/wnl.53.6.1319

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.